Genomma Lab Internacional SAB de CV (GNMLF) Q3 2024 Earnings Call Highlights: Strong Financial ...

By Yahoo! Finance | Oct 25, 2024 at 03:24 AM EST

Expect continued margin improvement aiming for 24-25% EBITDA by 2025 with reinvestment for growth. Recent isotonic acquisitions in Argentina focus on ibuprofen market. US strategy includes core categories, SKU reduction, and Hispanic brand expansion for sustained growth.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.